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HPA Axis Reactivity to Pharmacologic and Psychological Stressors in Euthymic Women 
with Histories of Postpartum versus Major Depression 
ABSTRACT 
Purpose: It is unclear whether women with a history of postpartum depression (PPD) have 
residual, abnormal hypothalamic-pituitary-adrenal (HPA) axis reactivity, as has been reported in 
major depression (MDD). Further unclear is whether the abnormalities in HPA axis reactivity 
associated with MDD represent a stable, underlying predisposition or a state-dependent 
phenomenon. This study sought the following: 1) to determine if euthymic postpartum women 
with a history of depression have an abnormal HPA axis reactivity to pharmacologic and 
psychological challenges and 2) to compare HPA reactivity in women with histories of PPD 
versus MDD. As a secondary objective, we wanted to determine the influence of trauma history 
on HPA axis function. 
Methods: Forty-five parous (12-24 months postpartum), euthymic women with history of MDD 
(n=15), PPD (n=15) and controls (n=15) completed pharmacologic (dexamethasone/CRH test 
[DEX/CRH]) and psychological (Trier Social Stress Test [TSST]) challenges during the luteal 
phase. Outcome measures were cortisol and adrenocorticotropic hormone (ACTH) response 
after DEX/CRH, and blood pressure, heart rate, epinephrine, norepinephrine, and cortisol 
response during the TSST.  
Results: All groups had robust cortisol and ACTH response to DEX/CRH and cortisol response 
to TSST. Groups did not differ significantly in cortisol or ACTH response to DEX/CRH or in 
blood pressure, heart rate, epinephrine, norepinephrine, or cortisol response to TSST. 
Cortisol/ACTH ratio did not differ significantly between groups. Trauma history was associated 
with decreased cortisol response to DEX/CRH in women with histories of MDD, which was not 
significant after correction (F8,125, p=0.02, Greenhouse-Geisser corrected p= 0.11).  
Conclusions: Currently euthymic women with histories of MDD or PPD did not demonstrate 
residual abnormal stress responsivity following administration of either a pharmacologic or 
psychological stressor. 
Keywords: postpartum depression; major depressive disorder; HPA axis; cortisol; Trier social 
stress test; dexamethasone/corticotropin-releasing hormone test 
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2Introduction 
Over the past five decades, many studies evaluating hypothalamic-pituitary-adrenal 
(HPA) axis reactivity in individuals with major depressive disorder (MDD) have demonstrated 
abnormal reactivity of the HPA axis in response to both pharmacologic and psychological 
stressors (Burke, Davis, Otte, & Mohr, 2005; Gold, Gabry, Yasuda, & Chrousos, 2002; Pariante 
& Lightman, 2008). This body of work has led to the hypothesis that abnormalities in HPA axis 
functioning may play a role in the pathogenesis of depression (Pariante & Lightman, 2008). The 
current study sought to better understand what role HPA axis abnormalities may play in the 
pathogenesis of postpartum depression (PPD), an important subtype of major depression that is 
associated with childbirth (Dietz et al., 2007; Glynn, Davis, & Sandman, 2013), through 
characterization of HPA axis reactivity to pharmacologic and psychological stressors in the 
postpartum period in euthymic women with histories of PPD compared to both women with 
histories of non-puerperal depression and healthy controls.  
It remains unclear whether abnormalities in HPA axis function in depression represent a 
stable, underlying predisposition or a state-dependent phenomenon of the disorder. More 
detailed investigations of HPA axis function in individuals with depression across time have led 
to conflicting results, with some studies finding a return to normal functioning of the HPA axis 
after successful antidepressant treatment (Anacker, Zunszain, Carvalho, & Pariante, 2011; 
Pariante, 2009; Ruhe et al., 2015; Schule, 2007) or during periods of euthymia (Lange et al., 
2013) and others reporting abnormalities of HPA axis function even during periods of remission 
from depression, including both hyper-reactivity (Hohne et al., 2014; Holsen et al., 2013; 
Keating, Dawood, Barton, Lambert, & Tilbrook, 2013; Lok et al., 2012) and hypo-reactivity 
(Ahrens et al., 2008; Bagley, Weaver, & Buchanan, 2011) of the HPA axis. Studies evaluating 
HPA axis reactivity in individuals with histories of early life stress have more consistently 
demonstrated persistent hyperreactivity of the HPA axis over time irrespective of current 
psychopathology/symptoms (Heim, Newport, Mletzko, Miller, & Nemeroff, 2008), leading to the 
3hypothesis that the finding of HPA axis hyperreactivity in individuals with depression represents 
an underlying biological predisposition to depression shaped by early life events rather than a 
transient biomarker of depressive symptoms (Pariante & Lightman, 2008). 
Significantly fewer studies have evaluated HPA axis reactivity in women with PPD. 
There are great alterations in the HPA axis during pregnancy, due in large part to the presence 
of the placenta, a highly active endocrine organ which produces its own CRH, as well as 
increases in gonadal hormones contributing to puerperal hypertrophy of both the pituitary and 
adrenal glands resulting in major increases in levels of ACTH and cortisol. During the 
postpartum period, after delivery of the placenta, there is an abrupt withdrawal of placentally-
derived CRH followed by slow decline in cortisol levels over the following months as the HPA 
axis returns to pre-pregnancy level of functioning (Glynn et al., 2013). Studies have consistently 
demonstrated hyporesponsivity of the HPA axis during the first few months postpartum, with 
some hypothesizing that this shift in HPA axis reactivity may play a role in the pathogenesis of 
PPD (Magiakou et al., 1996) along with shifts in reproductive hormones and changes in thyroid 
function, immune function, and genetic expression (Schiller, Meltzer-Brody, & Rubinow, 2015) 
observed during this period. Indeed, several studies have demonstrated an exaggeration of this 
postpartum hyporeactivity of the HPA axis in women with PPD with lower levels of morning 
cortisol (Groer & Morgan, 2007; Parry et al., 2003; Taylor, Glover, Marks, & Kammerer, 2009) 
as well as more severe and prolonged blunting of ACTH response to ovine CRH (Magiakou et 
al., 1996) compared to postpartum women without depression.  
Even fewer studies have been conducted to evaluate HPA reactivity in women with 
histories of PPD during periods of euthymia. One notable study evaluated the effects of 
administration followed by withdrawal of supraphysiologic doses of gonadal steroids (estrogen 
and progesterone), a scaled-down model of pregnancy and the puerperium, on cortisol 
response to ovine CRH in women who were currently euthymic with histories of PPD and found 
that these women demonstrated exaggerated cortisol response compared with controls, 
4suggesting possible HPA axis hyperreactivity during pregnancy in women who develop PPD 
(Bloch et al., 2005). It is not known whether this abnormality in HPA axis function exists in 
response to physiologic elevations in gonadal steroids outside of pregnancy, such as during the 
luteal phase of the menstrual cycle in euthymic women with histories of PPD.  
Similar to MDD outside of the perinatal period, early life stress appears to play a role in 
HPA axis reactivity in women with PPD, with studies demonstrating pronounced hyporeactivity 
of the HPA axis postpartum (Brand et al., 2010). This association with early life stress again led 
some to question if HPA axis dysfunction represents an underlying predisposition to depression 
rather than an associated phenomenon of the disorder, with this vulnerability being unmasked 
during the great alterations in HPA axis function in the perinatal period.  
Given the conflicting prior reports examining HPA axis dysregulation in MDD and PPD, 
in the present study, we sought to address one of the gaps in this body of literature. Specifically, 
we wanted to take the next logical step and examine HPA axis reactivity in euthymic women 
with histories of PPD under normal physiologic conditions in the luteal phase (as opposed to 
conditions of manipulated supraphysiologic levels of gonadal steroids). Therefore, the current 
study sought the following: 1) to determine if euthymic postpartum women with histories of 
depression have abnormalities in stimulated HPA axis reactivity to pharmacologic 
(dexamethasone/corticotropin-releasing hormone test [DEX/CRH test]) and psychological (Trier 
Social Stress Test [TSST]) challenges while exposed to normal physiologic elevations in 
gonadal steroids (the luteal phase of their menstrual cycle); and 2) to compare HPA reactivity in 
women with histories of PPD versus non-puerperal MDD. As a secondary objective, given the 
influence of early life stress on HPA axis reactivity in previous studies of MDD and PPD, we 
wanted to determine the influence of trauma history on HPA axis function in our sample of 
currently euthymic women. We hypothesized that women with a history of PPD would show 
increased HPA axis reactivity (higher plasma ACTH and cortisol levels) when given DEX/CRH 
5and administered the TSST compared with women without a history of PPD (including both non-
puerperal MDD and controls). 
Materials and Methods 
Participants 
The study was approved by the Biomedical Institutional Review Board, and all 
participants provided informed consent. Postpartum women were recruited from central North 
Carolina using fliers, advertisements in local printed media sources, and mass emails 
distributed at local universities from 2008 to 2014. A phone screening was conducted, and 
eligible participants were then invited to participate. Following informed consent, the participants 
were interviewed using the Structured Clinical Interview for DSM-IV (SCID) performed by a 
board-certified psychiatrist with extensive training in conducting structured clinical interviews 
(SMB) to assess for history of mood disorders, anxiety disorders (including trauma history 
elicited during assessment of the post-traumatic stress disorder module), substance use 
disorders, and psychotic disorders. Inclusion criteria included being 12-24 months postpartum 
and one of the following: 1) history of at least two weeks of post-partum related mood 
disturbance meeting criteria for major depressive episode (per SCID) occurring within three 
months of an uncomplicated vaginal delivery or Caesarean section (PPD group); 2) history of at 
least two weeks of mood disturbance meeting criteria for major depressive episode (per SCID) 
but without a major depressive episode in the perinatal period (MDD group); or 3) no history of a 
mood disorder (controls). Participants were excluded if they were taking any medications 
(including oral contraceptives), taking dietary or herbal supplements on a regular basis (with 
exception of a multivitamin), if they were currently pregnant or lactating, if they had a history of 
irregular menstrual cycles, if they had a serious medical illness (cardiac, pulmonary, hepatic, 
renal, cancer, diabetes) or abnormality on routine labwork performed at screening (complete 
blood count, chemistry, and thyroid stimulating hormone), if they currently met criteria for major 
6depressive episode, or if they had a history of moderate to severe lifetime psychiatric illness 
(other than that described above) including psychotic disorder, alcohol or other substance 
dependence, Bipolar I Disorder, or postpartum psychosis at any time in the past. 
Pharmacologic challenge: Dexamethasone/Corticotropin-releasing hormone test 
For the DEX/CRH test, participants presented 6-10 days following the LH surge as 
determined by home urinary testing (corresponding to luteal phase days 19-23 of an idealized 
28 day menstrual cycle), underwent a serum pregnancy test (participants were excluded if test 
was positive), and received 1.5 mg dexamethasone tablet, which they were instructed to take at 
23:00 that night before they returned for CRH testing. The next day, testing began uniformly at 
12:00 (with exception of one PPD participant and one MDD participant starting at 09:30) with 
participants having an intravenous (IV) catheter placed followed by a forty minute rest period. At 
the end of the rest period, participants were given 1 ug/kg ovine CRH by IV push. Participants 
were instructed to then rest with IV in place for the next three and a half hours. Blood samples 
for ACTH and cortisol were drawn 15 minutes before CRH administration, concurrent with CRH 
administration (time 0), and at 5, 15, 30, 60, 90, 120, 150, and 180 minutes after CRH 
administration.  
Psychological challenge: Trier social stress test 
 Within forty-eight hours of the pharmacologic challenge, participants underwent a 
psychological challenge with the TSST, performed during days 6-10 of the luteal phase of the 
menstrual cycle (as confirmed by home urinary testing). The TSST is a well validated stress test 
that includes a standardized speech task and a paced auditory serial subtraction task, and has 
been shown to induce large and consistent HPA axis and cardiovascular responses 
(Kirschbaum, Pirke, & Hellhammer, 1993). Testing was conducted beginning at 13:00. 
Participants had an IV catheter placed followed by a thirty minute rest period. The TSST was 
then conducted with the following components: Pre-stress baseline (10 minutes): Participants 
continued to rest for ten additional minutes, classified as pre-task baseline period, during which 
7time blood pressure and heart rate were measured every two minutes; blood pressure and heart 
rate continued to be measured every two minutes throughout the remainder of the TSST (but 
not recovery period). Blood was drawn to measure baseline epinephrine (EPI), norepinephrine 
(NE), and cortisol at the end of this ten minute baseline period. Pre-Task Instructions (5 
minutes): Participants were introduced to the ‘selection committee’, comprised of three 
individuals dressed in professional clothing, after which the participant was instructed to 
envision that she has been invited for a personnel interview with the company’s staff managers 
(the selection committee). The participant was informed that following a five minute quiet 
preparation period, she would be asked to give a free speech of five minutes in duration 
convincing the managers that she would be the perfect candidate for the position. All study 
participants were instructed that they would be audiorecorded for later performance review and 
that managers were specially trained to analyze their nonverbal behavior. Anticipation Period (5 
minutes): Participants were left alone to prepare their speech. Speech Task (5 minutes):
Participants then delivered their speech to the selection committee for the following five 
minutes; if a participant finished her speech before five minutes, managers responded with 
prepared questions to ensure participants spoke for the entire five minutes. Blood was drawn for 
EPI and NE one minute into speech delivery.  Paced Auditory Serial Addition Task (8 minutes):
Immediately following the speech task, participants underwent a paced auditory serial addition 
task guided via audiotape. Blood was drawn for EPI and NE two minutes into math task. Stress 
Recovery (60 minutes): Participants then underwent a stress recovery period for the following 
60 minutes with blood being drawn to measure cortisol at 10, 20, 30, and 60 minutes into 
recovery.   
Neuroendocrine marker assessment 
To summarize time-points of neuroendocrine assessment from detailed protocols above, 
during DEX/CRH testing, ACTH and cortisol were measured at time -15, 0, 5, 15, 30, 60, 90, 
120, 150, and 180 minutes relative to CRH administration. During the TSST, EPI and NE were 
8measured after ten-minute baseline rest period, one minute into speech task, and two minutes 
into math task, and cortisol was measured after ten-minute baseline rest period and 10, 20, 30, 
and 60 minutes into recovery period (since peak cortisol is reliably found 10 minutes after 
cessation of the TSST). Blood samples were collected into pre-chilled vacutainer tubes, 
immediately centrifuged, and plasma was pipetted into pre-chilled cryotubes and stored at -80°C 
until assay. We used commercial enzyme immunoassay kits to measure ACTH, cortisol, EPI, 
and NE. For ACTH, the level of detection was 5.7 pg/mL, with intra- and inter-assay variability of 
4.1% and 3.9%, respectively. For cortisol, the level of detection was .07 ug/dL, with intra- and 
inter-assay variability of 4.7% and 7.6%, respectively. For EPI, the level of detection was 10 
pg/ml, with intra- and inter-assay variability of 4.6% and 6.1%, respectively, and for NE, the level 
of detection was 50 pg/ml, with intra- and inter-assay variability of 4.0% and 10.1%, 
respectively. 
Statistical analysis 
All analyses were performed with SAS version 9.4. For demographic variables, 
differences between groups were evaluated using student’s t-tests for continuous variables and 
Fisher’s exact tests for categorical variables. Repeated measures analyses of variance 
(ANOVA) of log-transformed values [with one between subject factor (group) and one within 
subject factor (time)] were used to evaluate the effect of group on outcomes of cortisol and 
ACTH response to DEX/CRH, and on blood pressure, heart rate, EPI, NE, and cortisol response 
to TSST. ANOVAs were followed by area under the curve analyses for further characterization 
of influence of group on neuroendocrine markers of interest. To assess influence of trauma 
history on neuroendocrine responses to DEX/CRH and TSST, the entire sample and then 
groups (MDD, PPD, and controls) were analyzed separately using repeated measures ANOVA 
evaluating effect of trauma history on log-transformed outcome variables of ACTH and cortisol 
response to DEX/CRH and cortisol response to TSST.  Cortisol/ACTH ratios from DEX/CRH 
were compared between groups using ANOVA across time. All significance tests were two-
9tailed, and a p-value of <0.05 was considered significant. P values reported in this study were 
not corrected for multiple comparisons.  
Due to a shortage of commercially-available CRH in 2012, six participants did not 
undergo DEX/CRH testing when they participated in the study (one participant in the MDD 
group, three in the PPD group, and two controls). Data are missing from the first two 
participants recruited in each group for cortisol after TSST, as the protocol was adjusted early in 
the study to include more timepoints for measurement of cortisol after TSST (changed from one 
timepoint during TSST recovery to four timepoints; those with only one timepoint for cortisol 
were not included in analyses).  
A sample size of 15 women per group was chosen in order to have 90% power to detect 
differences in cortisol between groups over time in response to DEX/CRH test (α=0.05) based 
on previous work evaluating response to DEX/CRH test in women with PPD compared with 
controls (Bloch et al., 2005). 
Results 
Participant Characteristics 
Participants’ mean age was 31 years, mean education was 17 years, mean months 
postpartum was 18, and most participants were white (76%) and married (76%). Groups did not 
differ significantly on any of the baseline characteristics (Table 1). Mean number of lifetime 
major depressive episodes (MDEs) was 1.9 for women in the MDD group and 1.3 for women in 
the PPD group. No women in the PPD group reported history of a MDE outside of the 
peripartum period (four women reported histories of MDEs with multiple pregnancies). Three 
women (20%) in the PPD group had a lifetime history of trauma reported on the SCID compared 
with eight women (53%) in the MDD group and four women (27%) in the control group. Five 
women (33%) in the PPD group, five women (33%) in the MDD group, and no controls had a 
lifetime history of an anxiety disorder (including generalized anxiety disorder, post-traumatic 
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stress disorder, panic disorder, social anxiety disorder, specific phobia, obsessive-compulsive 
disorder, and anxiety disorder not otherwise specified). One woman (7%) in the MDD group and 
four women (27%) in the PPD group currently met criteria for anxiety disorder at the time of 
testing.  
Neuroendocrine Responses to DEX/CRH and TSST 
All groups demonstrated robust ACTH response to DEX/CRH (Figure 1A; average peak 
at 30 minutes post-CRH push) and robust cortisol response to DEX/CRH (Figure 2A; average 
peak at 180 minutes post-CRH push). There was a significant change in cortisol over time 
during recovery to TSST in all groups (Figure 3A, average peak at 10 minutes post-TSST; all p-
values for effect of time <0.0001). Groups did not differ significantly in ACTH (Figure 1B) or 
cortisol (Figure 2B) response to DEX/CRH or in blood pressure, heart rate, epinephrine, 
norepinephrine, or cortisol (Figure 3B) response to TSST (non-significant p-values for  group x 
time interaction in all ANOVAs and AUC analyses comparing groups).  Furthermore, 
cortisol/ACTH ratio did not differ significantly between groups (F2,36=0.58, p=0.56). 
Influence of Trauma History on Neuroendocrine Response 
Secondary analyses explored the effects of trauma history on neuroendocrine responses 
to stress in our sample. Trauma history was not significantly associated with differences in 
cortisol or ACTH responses to DEX/CRH or cortisol response to TSST in the full sample or in 
PPD or control groups separately, though sample sizes were small with only three women 
having a history of trauma in the PPD group and four women having a history of trauma in the 
control group. 
In the MDD group analysis, there were seven women with history of trauma (one of the 
eight women with MDD and history of trauma was missing DEX/CRH data and thus not included 
in the analysis) and seven women without history of trauma. In evaluation of response to 
DEX/CRH, main effects for trauma were F1,12=3.21 p=0.098. Trauma by time interaction effects 
were significant (F8,125= 2.37 p=0.02), with women with histories of trauma having decreased 
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cortisol response to DEX/CRH at time 0, 15, and 30 minutes post-CRH push; however, 
Mauchly’s test statistic indicated the assumption of sphericity was violated (x2 143.1, p<.001). 
The degrees of freedom were corrected using the Greenhouse-Geisser estimates of sphericity 
(ε= .24), and the adjusted interaction effects supported a trauma*time trend (p=0.11) that was 
no longer statistically significant. Trauma history was not significantly associated with 
differences in ACTH response to DEX/CRH or cortisol response to TSST in the MDD group. 
The small sample of fourteen women in the MDD group had 38% power to detect main level 
differences at the 0.05 level.    
Discussion 
We sought to study HPA axis reactivity in response to both a pharmacologic and 
psychological challenge in euthymic women with a history of PPD compared with postpartum 
women with a history of non-puerperal depression or control women. As a secondary objective, 
we wanted to determine the influence of trauma history on HPA axis reactivity in our sample of 
currently euthymic women. We found that neither women with history of PPD nor MDD showed 
significant residual stress axis abnormality following either a pharmacologic or psychological 
stressor, with the exception of a trend toward blunting of cortisol response to DEX/CRH in 
women with histories of MDD who have also experienced past trauma.  
These findings differ from previous studies showing abnormalities in the HPA axis exist 
even during periods of euthymia in MDD (Hohne et al., 2014; Holsen et al., 2013; Keating et al., 
2013; Lok et al., 2012). It is possible that we were unable to detect this effect in our small 
sample powered only to detect large effect sizes. Other possible explanations for the 
discrepancy in findings include differences in samples in terms of severity of depressive history 
(average of only 1.9 and 1.3 lifetime depressive episodes in women with MDD and PPD, 
respectively, in our sample), timing of onset of previous depressive episodes relative to the time 
of study enrollment, and comorbid trauma history, all of which are known to influence HPA axis 
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reactivity (Heim et al., 2008; Kunzel et al., 2003; Lok et al., 2012; Sher et al., 2004). Indeed, 
trauma history in our sample of women with MDD was associated with a trend toward 
hyporeactivity of cortisol response to DEX/CRH. Our findings, in line with previous work 
evaluating early life stress and the HPA axis, suggest that history of trauma may be the greater 
predictor of lasting HPA axis dysregulation rather than history of depression (Pariante & 
Lightman, 2008). Similar to our study, others have reported normal HPA axis reactivity after 
resolution of a major depressive episode (Lange et al., 2013) and with successful 
antidepressant treatment (Anacker et al., 2011; Pariante, 2009; Ruhe et al., 2015; Schule, 
2007). It is also possible that divergent HPA axis responses within our sample -  with some 
individuals displaying hyperreactivity of the HPA axis commonly reported in MDD and others 
displaying the hyporeactivity described in individuals with severe and repeated early life stress 
(Carpenter et al., 2009; Lee et al., 2012; MacMillan et al., 2009) -  may have offset each other, 
resulting in no observed effect.  To address this question, we conducted a post-hoc analysis 
dividing cortisol and ACTH responses to DEX/CRH and cortisol responses to TSST into normal 
and abnormal (upper and lower 10% of responses) categories for each group and conducted 
chi-square analyses, the results of which were not significant. 
 These findings also differ from the study by Bloch et. al (2005) demonstrating 
abnormalities in HPA axis reactivity in euthymic women with histories of PPD when exposed to 
supraphysiologic doses of gonadal steroids mimicking pregnancy. In our study, we evaluated 
women during the luteal phase of their menstrual cycle at the peak of physiologic levels of 
gonadal steroids. Taken together, these results suggest that women with histories of PPD may 
have a vulnerability in HPA axis reactivity that is unmasked when exposed to the large shift in 
levels of gonadal steroids during the transition from pregnancy to the postpartum period but not 
in response to the smaller changes in gonadal steroid levels accompanying the normal 
menstrual cycle. This emphasizes the potential pathophysiologic distinction between PPD and 
PMDD; although both are reproductive mood disorders, PMDD is a luteal phase disorder that is 
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distinct from PPD. Further, the literature demonstrates that having one type of reproductive 
mood disorder is not necessarily associated with onset of other reproductive mood disorders
and that there are likely some differences in underlying pathophysiology (Buttner et al., 2013; 
Kepple et al., 2016).
 Trauma history was not significantly associated with HPA axis abnormalities in our 
sample of euthymic postpartum women as a whole or in PPD, MDD, or control groups when 
analyzed individually (an effect seen in MDD group was not significant after correcting for 
violation of sphericity). This did represent an exploratory analysis for a secondary objective; 
sample sizes were exceedingly small, resulting in limited power to detect anything but very large 
effect sizes, so further investigation with a larger sample is needed. A further limitation in our 
study was the use of the SCID to assess trauma history rather than the use of a more detailed, 
validated trauma-specific instrument, which could be used in future studies. If our initial finding 
of HPA axis hyporeactivity (prior to statistical correction) in women with histories of both MDD 
and trauma is found to be significant in larger samples, this would help confirm earlier 
suggestions that trauma has an enduring influence on HPA axis function that may be a 
mediating variable in the increased risk of depression observed in those with a history of 
trauma.  
 Several limitations should be considered when interpreting our results. First, the sample 
size was selected to have the power to detect only large effect sizes in an effort to account for 
the difficulty of recruiting women during the second year post-partum. Given our limited power to 
detect smaller effects, failure to detect a significant effect does not imply that an effect does not 
exist. This is particularly true in analyses for the secondary objective of evaluating the effect of 
trauma history on HPA axis reactivity in which the sample sizes were increasingly small.  
Second, while all women in the present study were currently euthymic, there were a number of 
women in the MDD and PPD groups with current symptoms of anxiety, which may have 
influenced results, masking any underlying differences between these groups due to history of 
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puerperal versus non-puerperal depression. Previous work has demonstrated an association of 
concurrent anxiety disorder in MDD (unlike our study with comorbidity but not concurrent 
symptoms) with hyperreactivity of the HPA axis (Young, Abelson, & Cameron, 2004). Lastly, 
although we intentionally studied women during the luteal phase of their menstrual cycle to 
assure peak physiologic levels of gonadal steroids, the luteal phase is also known to enhance 
HPA axis activity (Roca et al., 2003), which may have masked any underlying HPA axis 
hyporeactivity present in our sample.  
Conclusion 
Currently euthymic women with histories of PPD or MDD did not demonstrate residual 
abnormal stress responsivity following administration of either a pharmacologic or psychological 
stressor, with the exception of a trend toward blunting of cortisol response to DEX/CRH in 
women with history of both MDD and past trauma. This suggests that the appearance of 
residual abnormal HPA axis stress response in prior studies in those with MDD histories may 
reflect the following: 1) ongoing dysphoric symptoms at the time of testing, 2) greater 
severity/duration or more episodes of prior depression, or 3) the presence of comorbid trauma 
history. Differences between groups may have been blunted in our study due to known 
enhancement of HPA axis performance in the luteal phase. Future work should further 
investigate the contribution of trauma history to persistent HPA axis dysregulation and other 
biological systems that may have a lasting impact on mental and physical health, particularly, 
during the vulnerable perinatal period. 
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Controls (n=15) MDD (n=15) PPD (n=15)
Age (y)* 30.5 (4.2) 31.9 (4.9) 31.5 (4.3)
Education (y) 17.3 (2.4) 16.7 (2.1) 16.9 (2.7)
Months Postpartum 17.3 (3.0) 17.9 (3.5) 18.2 (3.4) 
Ethnicity**
White 11 (73%) 11 (73%) 12 (80%)
Hispanic 1 (7%) 0 1 (7%)
Black/African American 3 (20%) 3 (20%) 2 (13%)
Asian 0 0 0
Native Hawaiian/Other Pacific 0 0 0
Other 0 1 (7%) 0
Marital Status
Single, never married 4 (27%) 3 (20%) 1 (7%)
Living with a partner unmarried 0 0 1 (7%)
Married 11 (73%) 12 (80%) 11 (73%)
Divorced/Separated 0 0 2 (13%)
Widowed 0 0 0
* Age, education, and months postpartum expressed as mean(SD) 
** Ethnicity and marital status expressed as number(percentage)
Abbreviations: MDD: major depressive disorder; PPD: postpartum depression
Table 1. Demographic characteristics of participants 
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Figure 1. All groups demonstrate rise in ACTH (A) after DEX/CRH with 
area under curve analysis demonstrating no significant difference between 
groups (B) 
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Figure 2. All groups demonstrate rise in cortisol (A) after 
DEX/CRH with area under curve analysis demonstrating no 
significant difference between groups (B) 
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